全文获取类型
收费全文 | 5470篇 |
免费 | 341篇 |
国内免费 | 2篇 |
出版年
2023年 | 28篇 |
2022年 | 49篇 |
2021年 | 104篇 |
2020年 | 61篇 |
2019年 | 94篇 |
2018年 | 122篇 |
2017年 | 111篇 |
2016年 | 137篇 |
2015年 | 267篇 |
2014年 | 265篇 |
2013年 | 426篇 |
2012年 | 445篇 |
2011年 | 419篇 |
2010年 | 255篇 |
2009年 | 215篇 |
2008年 | 357篇 |
2007年 | 334篇 |
2006年 | 286篇 |
2005年 | 290篇 |
2004年 | 242篇 |
2003年 | 248篇 |
2002年 | 221篇 |
2001年 | 35篇 |
2000年 | 30篇 |
1999年 | 55篇 |
1998年 | 56篇 |
1997年 | 40篇 |
1996年 | 38篇 |
1995年 | 40篇 |
1994年 | 35篇 |
1993年 | 23篇 |
1992年 | 28篇 |
1991年 | 23篇 |
1990年 | 30篇 |
1989年 | 40篇 |
1988年 | 19篇 |
1987年 | 16篇 |
1986年 | 23篇 |
1985年 | 16篇 |
1984年 | 31篇 |
1983年 | 18篇 |
1982年 | 26篇 |
1981年 | 12篇 |
1980年 | 20篇 |
1979年 | 27篇 |
1978年 | 12篇 |
1977年 | 23篇 |
1976年 | 21篇 |
1975年 | 16篇 |
1974年 | 13篇 |
排序方式: 共有5813条查询结果,搜索用时 15 毫秒
991.
Pittalà V Romeo G Salerno L Siracusa MA Modica M Materia L Mereghetti I Cagnotto A Mennini T Marucci G Angeli P Russo F 《Bioorganic & medicinal chemistry letters》2006,16(1):150-153
The discovery of a new series of selective and high-affinity alpha(1)-adrenoceptor (alpha(1)-AR) ligands, characterized by a 1H-pyrrolo[2,3-d]-pyrimidine-2,4(3H,7H)-dione system, is described in this paper. Some synthesized compounds, including 20, 22, and 30, displayed affinity in the nanomolar range for alpha(1)-ARs and substantial selectivity with respect to 5-HT(1A) and dopaminergic D(1) and D(2) receptors. Functional assays, performed on selected derivatives, showed antagonistic properties. 相似文献
992.
Mugnaini C Manetti F Esté JA Clotet-Codina I Maga G Cancio R Botta M Corelli F 《Bioorganic & medicinal chemistry letters》2006,16(13):3541-3544
S-Aryl-S-DABO derivatives, a novel subclass of S-DABO anti-HIV-1 agents, were synthesized via Ullmann type reaction starting from the corresponding 2-thiouracils by the aid of microwave irradiation. The results of their evaluation as inhibitors of RT are reported together with their antiviral activity in cellular assays. 相似文献
993.
Rivara M Zuliani V Cocconcelli G Morini G Comini M Rivara S Mor M Bordi F Barocelli E Ballabeni V Bertoni S Plazzi PV 《Bioorganic & medicinal chemistry》2006,14(5):1413-1424
A novel series of non-imidazole H(3)-receptor antagonists was developed, by chemical modification of a potent lead H(3)-antagonist composed by an imidazole ring connected through an alkyl spacer to a 2-aminobenzimidazole moiety (e.g., 2-[[3-[4(5)-imidazolyl]propyl]amino]benzimidazole), previously reported by our research group. We investigated whether the removal of the imidazole ring could allow retaining high affinity for the H(3)-receptor, thanks to the interactions undertaken by the 2-aminobenzimidazole moiety at the binding site. The imidazole ring of the lead was replaced by a basic piperidine or by a lipophilic p-chlorophenoxy substituent, modulating the spacer length from three to eight methylene groups; moreover, the substituents were moved to the 5(6) position of the benzimidazole nucleus. Within both the 2-alkylaminobenzimidazole series and the 5(6)-alkoxy-2-aminobenzimidazole one, the greatest H(3)-receptor affinity was obtained for the piperidine-substituted compounds, while the presence of the p-chlorophenoxy group resulted in a drop in affinity. The optimal chain length was different in the two series. Even if the new compounds did not reach the high receptor affinity shown by the imidazole-containing lead compound, it was possible to get good H(3)-antagonist potencies with 2-aminobenzimidazoles having a tertiary amino group at appropriate distance. 相似文献
994.
Hidalgo P Gonzalez-Gutierrez G Garcia-Olivares J Neely A 《The Journal of biological chemistry》2006,281(34):24104-24110
High voltage-gated calcium channels consist of a pore-forming subunit (alpha(1)) and three nonhomologous subunits (alpha(2)/delta, beta, and gamma). Although it is well established that the beta-subunit promotes traffic of channels to the plasma membrane and modifies their activity, the reversible nature of the interaction with the alpha(1)-subunit remains controversial. Here, we address this issue by examining the effect of purified beta(2a) protein on Ca(V)1.2 and Ca(V)2.3 channels expressed in Xenopus oocytes. The beta(2a)-subunit binds to the alpha(1)-interaction domain (AID) in vitro, and when injected into oocytes, it shifts the voltage dependence of activation and increases charge movement to ionic current coupling of Ca(V)1.2 channels. This increase depended on the integrity of AID but was not abolished by bafilomycin, demonstrating that the alpha(1)-beta interaction through the AID site can take place at the plasma membrane. Furthermore, injection of beta(2a) protein inhibited inactivation of Ca(V)2.3 channels and converted fast inactivating Ca(V)2.3/beta(1b) channels to slow inactivating channels. Inhibition of inactivation required larger concentration of beta(2a) in oocytes expressing Ca(V)2.3/beta(1b) channels than expressing Ca(V)2.3 alone but reached the same maximal level as expected for a competitive interaction through a single binding site. Together, our data show that the alpha(1)-beta interaction is reversible in intact cells and defines calcium channels beta-subunits as regulatory proteins rather than stoichiometric subunits. 相似文献
995.
996.
Eva Pericolini Elena Gabrielli Giovanni Bistoni Elio Cenci Stefano Perito Siu-Kei Chow Francesca Riuzzi Rosario Donato Arturo Casadevall Anna Vecchiarelli 《PloS one》2010,5(9)
Previously, we reported that Galactoxylomannan (GalXM) activates the extrinsic and intrinsic apoptotic pathways through an interaction with the glycoreceptors on T cells. In this study we establish the role of the glycoreceptor CD45 in GalXM-induced T cell apoptosis, using CD45+/+ and CD45−/− cell lines, derived from BW5147 murine T cell lymphoma. Our results show that whereas CD45 expression is not required for GalXM association by the cells, it is essential for apoptosis induction. In CD45+/+ cells, CD45 triggering by GalXM reduces the activation of Lck, ZAP70 and Erk1/2. Conversely, in CD45−/− cells, Lck was hyperphosphorylated and did not show any modulation after GalXM stimulation. On the whole, our findings provide evidence that the negative regulation of Lck activation occurs via CD45 engagement. This appears to be related to the capacity of GalXM to antagonize T cell activation and induce T cell death. Overall this mechanism may be responsible for the immune paralysis that follows GalXM administration and could explain the powerful immunosuppression that accompanies cryptococcosis. 相似文献
997.
Dante Mantini Francesca Petrucci Damiana Pieragostino Piero Del Boccio Paolo Sacchetta Giovanni Candiano Gian Marco Ghiggeri Alessandra Lugaresi Giorgio Federici Carmine Di Ilio Andrea Urbani 《Journal of Proteomics》2010,73(3):562-570
BackgroundMass spectrometry (MS) is becoming the gold standard for biomarker discovery. Several MS-based bioinformatics methods have been proposed for this application, but the divergence of the findings by different research groups on the same MS data suggests that the definition of a reliable method has not been achieved yet. In this work, we propose an integrated software platform, MASCAP, intended for comparative biomarker detection from MALDI-TOF MS data.ResultsMASCAP integrates denoising and feature extraction algorithms, which have already shown to provide consistent peaks across mass spectra; furthermore, it relies on statistical analysis and graphical tools to compare the results between groups. The effectiveness in mass spectrum processing is demonstrated using MALDI-TOF data, as well as SELDI-TOF data. The usefulness in detecting potential protein biomarkers is shown comparing MALDI-TOF mass spectra collected from serum and plasma samples belonging to the same clinical population.ConclusionsThe analysis approach implemented in MASCAP may simplify biomarker detection, by assisting the recognition of proteomic expression signatures of the disease. A MATLAB implementation of the software and the data used for its validation are available at http://www.unich.it/proteomica/bioinf. 相似文献
998.
Isabella Russo Monica Traversa Katia Bonomo Alessandro De Salve Luigi Mattiello Paola Del Mese Gabriella Doronzo Franco Cavalot Mariella Trovati Giovanni Anfossi 《Obesity (Silver Spring, Md.)》2010,18(4):788-797
Central obesity shows impaired platelet responses to the antiaggregating effects of nitric oxide (NO), prostacyclin, and their effectors—guanosine 3′,5′‐cyclic monophosphate (cGMP) and adenosine 3′,5′‐cyclic monophosphate (cAMP). The influence of weight loss on these alterations is not known. To evaluate whether a diet‐induced body‐weight reduction restores platelet sensitivity to the physiological antiaggregating agents and reduces platelet activation in subjects affected by central obesity, we studied 20 centrally obese subjects before and after a 6‐month diet intervention aiming at reducing body weight by 10%, by measuring (i) insulin sensitivity (homeostasis model assessment of insulin resistance (HOMAIR)); (ii) plasma lipids; (iii) circulating markers of inflammation of adipose tissue and endothelial dysfunction, and of platelet activation (i.e., soluble CD‐40 ligand (sCD‐40L) and soluble P‐selectin (sP‐selectin)); (iv) ability of the NO donor sodium nitroprusside (SNP), the prostacyclin analog Iloprost and the cyclic nucleotide analogs 8‐bromoguanosine 3′,5′‐cyclic monophosphate (8‐Br‐cGMP) and 8‐bromoadenosine 3′,5′‐cyclic monophosphate (8‐Br‐cAMP) to reduce platelet aggregation in response to adenosine‐5‐diphosphate (ADP); and (v) ability of SNP and Iloprost to increase cGMP and cAMP. The 10 subjects who reached the body‐weight target showed significant reductions of insulin resistance, adipose tissue, endothelial dysfunction, and platelet activation, and a significant increase of the ability of SNP, Iloprost, 8‐Br‐cGMP, and 8‐Br‐cAMP to reduce ADP‐induced platelet aggregation and of the ability of SNP and Iloprost to increase cyclic nucleotide concentrations. No change was observed in the 10 subjects who did not reach the body‐weight target. Changes of platelet function correlated with changes of HOMAIR. Thus, in central obesity, diet‐induced weight loss reduces platelet activation and restores the sensitivity to the physiological antiaggregating agents, with a correlation with improvements in insulin sensitivity. 相似文献
999.
1000.